BRIEF-FDA grants Pluristem Orphan Drug Designation for its PLX-R18 cell therapy
October 19, 2017 at 07:58 AM EDT
* FDA grants Pluristem Orphan Drug Designation for its PLX-R18 cell therapy as treatment for acute radiation syndrome Source text for Eikon: Further company coverage:
